UNSPSC 85552866: Release right lacrimal gland, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to release right lacrimal gland, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 08NV3ZZ

UNSPSC 85552866 Release right lacrimal gland, percutaneous approach is a Commodity code with no relevant recent activity in state and local procurement. The code nominally describes a surgical procedure on the lacrimal gland; however, recent opportunities posted under this code span independent medical evaluation services, surgery benefit carve-outs, occupational medical surveillance, emergency and specialty medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—none of which align with lacrimal gland surgery or ophthalmologic procedures. The mismatch between the code's clinical scope and the actual work being solicited suggests either a data-entry error in code assignment or a fundamental misclassification within the posting system.

The issuing bodies across these opportunities include city retirement offices (Phoenix), municipal health systems (Long Beach, Santa Clara), state transportation agencies (Washington State Department of Transportation), county probation departments (Harris County), and county commissions (Collier County). Geographic spread spans Arizona, California, Washington, Florida, and Texas. Recent opportunities include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026, $750,000 over five years), the City of Long Beach's RFP for a surgical and medical procedure carve-out benefit program (HR26753, due October 7, 2026), and the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026). None of these solicitations concern lacrimal gland procedures, and procurement under this code does not appear to support business development pursuit focused on its nominal clinical scope.